BMLL — Bio Medica Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual income statement for Bio Medica Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	PROSPECTUS	PROSPECTUS	PROSPECTUS	PRESS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Preliminary
Revenue
Total Revenue	212	162	152	382	431
Cost of Revenue
Gross Profit	45.1	47.6	85.8	191	256
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	199	150	107	238	246
Operating Profit	13.5	12	45.2	144	185
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7.97	4.52	36.5	131	163
Provision for Income Taxes
Net Income After Taxes	5.89	3.33	25	97.9	119
Net Income Before Extraordinary Items
Net Income	5.89	3.33	25	97.9	119
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5.89	3.33	25	97.9	119
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.468	0.265	1.99	7.79	12.9